From: Is it sufficient to evaluate bone marrow involvement in newly diagnosed lymphomas using 18F-FDG PET/CT and/or routine iliac crest biopsy? A new approach of PET/CT-guided targeted bone marrow biopsy
Pathological results
Total
P
+
–
Target bone biopsy(n = 30)
27 (90.0%)
3a (10.0%)
30
< 0.05‡
Routine iliac crest biopsy(n = 30)
5 (16.7%)
25 (83.3%)